News

Home News Page 2
- Advertisement -

APPLE

Hemispherx Biopharma Announces IRB Approval of Clinical Study in Metastatic Triple...

The Phase II Study Will Combine Hemispherx’s Ampligen with Keytruda OCALA, Fla., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an...

RECENT POSTS

381cf01438895cab0b3756fba2d0131142708ac5e7aa3f1832